- Home
- MTG vs CORT Comparison
MTG vs CORT Comparison
Compare MTG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTG
- CORT
- Stock Information
- Founded
- MTG 1957
- CORT 1998
- Country
- MTG United States
- CORT United States
- Employees
- MTG N/A
- CORT N/A
- Industry
- MTG Property-Casualty Insurers
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- MTG Finance
- CORT Health Care
- Exchange
- MTG Nasdaq
- CORT Nasdaq
- Market Cap
- MTG 6.0B
- CORT 7.1B
- IPO Year
- MTG 1991
- CORT N/A
- Fundamental
- Price
- MTG $25.54
- CORT $83.81
- Analyst Decision
- MTG Hold
- CORT Strong Buy
- Analyst Count
- MTG 8
- CORT 4
- Target Price
- MTG $26.75
- CORT $130.00
- AVG Volume (30 Days)
- MTG 3.5M
- CORT 2.0M
- Earning Date
- MTG 04-30-2025
- CORT 04-30-2025
- Dividend Yield
- MTG 2.04%
- CORT N/A
- EPS Growth
- MTG 16.23
- CORT 30.85
- EPS
- MTG 2.89
- CORT 1.23
- Revenue
- MTG $1,207,731,000.00
- CORT $675,040,000.00
- Revenue This Year
- MTG $3.42
- CORT $36.81
- Revenue Next Year
- MTG $2.72
- CORT $29.94
- P/E Ratio
- MTG $8.80
- CORT $74.74
- Revenue Growth
- MTG 4.56
- CORT 39.94
- 52 Week Low
- MTG $19.26
- CORT $20.84
- 52 Week High
- MTG $26.56
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- MTG 67.39
- CORT 60.19
- Support Level
- MTG $24.19
- CORT $53.79
- Resistance Level
- MTG $25.01
- CORT $117.33
- Average True Range (ATR)
- MTG 0.52
- CORT 6.32
- MACD
- MTG 0.25
- CORT 4.16
- Stochastic Oscillator
- MTG 99.23
- CORT 47.25
About MTG MGIC Investment Corporation
MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.